TNFAIP3 and type 1 diabetes mellitus: The liver function was improved by using ursodeoxycholic acid 0.75 mg/d during the follow-up.<h4>Conclusion</h4>We report a novel pathogenic mutation in <i>TNFAIP3</i> that results in HA20 in a patient with T1DM.